Pamela J. Cramer's most recent trade in Rhythm Pharmaceuticals Inc. was a trade of 10,547 Common Stock done at an average price of $6.8 . Disclosure was reported to the exchange on July 9, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.80 per share. | 09 Jul 2025 | 10,547 | 29,756 (0%) | 0% | 6.8 | 71,720 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 10,547 | 17,581 | - | - | Stock Options (Right to Buy) | |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 76.69 per share. | 09 Jul 2025 | 7,831 | 22,725 (0%) | 0% | 76.7 | 600,565 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 5,025 | 15,075 | - | - | Stock Options (Right to Buy) | |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.35 per share. | 09 Jul 2025 | 5,025 | 34,781 (0%) | 0% | 27.4 | 137,434 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 75.55 per share. | 09 Jul 2025 | 4,225 | 30,556 (0%) | 0% | 75.6 | 319,217 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 80.00 per share. | 09 Jul 2025 | 3,516 | 19,209 (0%) | 0% | 80 | 281,280 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.80 per share. | 06 Jun 2025 | 7,031 | 26,240 (0%) | 0% | 6.8 | 47,811 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2025 | 7,031 | 28,128 | - | - | Stock Options (Right to Buy) | |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 68.05 per share. | 06 Jun 2025 | 7,031 | 19,209 (0%) | 0% | 68.0 | 478,435 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2025 | 7,031 | 35,159 | - | - | Stock Options (Right to Buy) | |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 65.09 per share. | 29 Apr 2025 | 7,031 | 19,209 (0%) | 0% | 65.1 | 457,663 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.80 per share. | 29 Apr 2025 | 7,031 | 26,240 (0%) | 0% | 6.8 | 47,811 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2025 | 14,060 | 42,190 | - | - | Stock Options (Right to Buy) | |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.80 per share. | 08 Apr 2025 | 14,060 | 33,269 (0%) | 0% | 6.8 | 95,608 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 62.00 per share. | 08 Apr 2025 | 7,030 | 19,209 (0%) | 0% | 62 | 435,860 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 08 Apr 2025 | 6,700 | 26,239 (0%) | 0% | 60 | 402,000 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.35 per share. | 08 Apr 2025 | 6,700 | 39,969 (0%) | 0% | 27.4 | 183,245 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Apr 2025 | 6,700 | 20,100 | - | - | Stock Options (Right to Buy) | |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 58.36 per share. | 08 Apr 2025 | 6,430 | 33,539 (0%) | 0% | 58.4 | 375,230 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 59.00 per share. | 08 Apr 2025 | 600 | 32,939 (0%) | 0% | 59 | 35,400 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 30,000 | 30,000 | - | - | Stock Options (Right to Buy) | |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 20,000 | 20,000 | - | - | Restricted Stock Units | |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 3,300 | 9,900 | - | - | Restricted Stock Units | |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 3,300 | 20,191 (0%) | 0% | - | Common Stock | |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 57.22 per share. | 14 Feb 2025 | 982 | 19,209 (0%) | 0% | 57.2 | 56,190 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2025 | 2,344 | 2,343 | - | - | Restricted Stock Units | |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2025 | 2,344 | 17,592 (0%) | 0% | - | Common Stock | |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 57.51 per share. | 09 Feb 2025 | 698 | 16,894 (0%) | 0% | 57.5 | 40,142 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 57.67 per share. | 09 Feb 2025 | 3 | 16,891 (0%) | 0% | 57.7 | 173 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 2,650 | 16,150 (0%) | 0% | - | Common Stock | |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 2,650 | 5,300 | - | - | Restricted Stock Units | |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 59.43 per share. | 01 Feb 2025 | 902 | 15,248 (0%) | 0% | 59.4 | 53,606 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Nov 2024 | 4,688 | 14,062 | - | - | Stock Options (Right to buy) | |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 65.00 per share. | 06 Nov 2024 | 4,688 | 13,500 (0%) | 0% | 65 | 304,720 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.02 per share. | 06 Nov 2024 | 4,688 | 18,188 (0%) | 0% | 19.0 | 89,166 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Nov 2024 | 4,687 | 18,750 | - | - | Stock Options (Right to buy) | |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 06 Nov 2024 | 4,687 | 13,500 (0%) | 0% | 60 | 281,220 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.02 per share. | 06 Nov 2024 | 4,687 | 18,187 (0%) | 0% | 19.0 | 89,147 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.02 per share. | 09 Sep 2024 | 4,099 | 17,599 (0%) | 0% | 19.0 | 77,963 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 50.03 per share. | 09 Sep 2024 | 4,099 | 13,500 (0%) | 0% | 50.0 | 205,062 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Sep 2024 | 4,099 | 23,437 | - | - | Stock Options (Right to buy) | |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Aug 2024 | 3,200 | 27,536 | - | - | Stock Options (Right to buy) | |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 50.01 per share. | 26 Aug 2024 | 3,200 | 13,500 (0%) | 0% | 50.0 | 160,018 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.02 per share. | 26 Aug 2024 | 3,200 | 16,700 (0%) | 0% | 19.0 | 60,864 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 45.13 per share. | 09 Aug 2024 | 46,902 | 15,604 (0%) | 0% | 45.1 | 2,116,509 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2024 | 30,771 | 30,736 | - | - | Stock Options (Right to buy) | |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.02 per share. | 09 Aug 2024 | 30,771 | 62,506 (0%) | 0% | 19.0 | 585,264 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 45.62 per share. | 09 Aug 2024 | 2,104 | 13,500 (0%) | 0% | 45.6 | 95,989 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jul 2024 | 3,125 | 3,125 | - | - | Restricted Stock Units | |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jul 2024 | 3,125 | 33,130 (0%) | 0% | - | Common Stock | |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 49.06 per share. | 26 Jul 2024 | 1,395 | 31,735 (0%) | 0% | 49.1 | 68,439 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 39.22 per share. | 19 Mar 2024 | 15,515 | 30,005 (0%) | 0% | 39.2 | 608,498 | Common Stock |
Rhythm Pharmaceuticals Inc. | J. Pamela Cramer | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 40,200 | 40,200 | - | - | Stock Option (Right to Buy) | |
Rhythm Pharmaceuticals Inc. | Pamela Cramer J. | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 33,750 | 45,520 (0%) | 0% | 0 | Common Stock | |
Rhythm Pharmaceuticals Inc. | Cramer Pamela J. | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 13,200 | 13,200 | - | - | Restricted Stock Units | |
Rhythm Pharmaceuticals Inc. | J. Cramer Pamela | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 2,344 | 12,466 (0%) | 0% | - | Common Stock | |
Rhythm Pharmaceuticals Inc. | Cramer J. Pamela | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 2,344 | 4,687 | - | - | Restricted Stock Units | |
Rhythm Pharmaceuticals Inc. | Cramer Pamela J. | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 51.38 per share. | 09 Feb 2024 | 696 | 11,770 (0%) | 0% | 51.4 | 35,760 | Common Stock |
Rhythm Pharmaceuticals Inc. | Cramer J. Pamela | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 2,650 | 7,950 | - | - | Restricted Stock Units | |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 2,650 | 11,068 (0%) | 0% | - | Common Stock | |
Rhythm Pharmaceuticals Inc. | Pamela Cramer J. | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 45.06 per share. | 01 Feb 2024 | 946 | 10,122 (0%) | 0% | 45.1 | 42,627 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 27.51 per share. | 09 Feb 2023 | 843 | 6,142 (0%) | 0% | 27.5 | 23,191 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 26,800 | 26,800 | - | - | Stock Option (Right to Buy) | |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 10,600 | 10,600 | - | - | Restricted Stock Units | |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2022 | 13,493 | 61,507 | - | - | Stock Option (Right to Buy) | |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 24.83 per share. | 19 Aug 2022 | 13,493 | 2,224 (0%) | 0% | 24.8 | 335,031 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.02 per share. | 19 Aug 2022 | 13,493 | 15,717 (0%) | 0% | 19.0 | 256,637 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jul 2022 | 3,125 | 9,375 | - | - | Restricted Stock Units | |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jul 2022 | 3,125 | 3,125 (0%) | 0% | - | Common Stock | |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 11.68 per share. | 26 Jul 2022 | 901 | 2,224 (0%) | 0% | 11.7 | 10,524 | Common Stock |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2021 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2021 | 12,500 | 12,500 | - | - | Restricted Stock Units |